📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data. (2017)

First Author: Laxy M

Attributed to: Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2017.05.018

PubMed Identifier: 29241888

Publication URI: http://europepmc.org/abstract/MED/29241888

Type: Journal Article/Review

Volume: 20

Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Issue: 10

ISSN: 1098-3015